Literature DB >> 19422391

The local anaesthetics proadifen and adiphenine inhibit nicotinic receptors by different molecular mechanisms.

Guillermo Spitzmaul1, Fernanda Gumilar, James P Dilger, Cecilia Bouzat.   

Abstract

BACKGROUND AND
PURPOSE: Many local anaesthetics are non-competitive inhibitors of nicotinic receptors (acetylcholine receptor, AChR). Proadifen induces a high-affinity state of the receptor, but its mechanism of action and that of an analogue, adiphenine, is unknown. EXPERIMENTAL APPROACH: We measured the effects of proadifen and adiphenine on single-channel and macroscopic currents of adult mouse muscle AChR (wild-type and mutant). We assessed the results in terms of mechanisms and sites of action. KEY
RESULTS: Both proadifen and adiphenine decreased the frequency of ACh-induced single-channel currents. Proadifen did not change cluster properties, but adiphenine decreased cluster duration (36-fold at 100 micromolxL(-1)). Preincubation with proadifen decreased the amplitude (IC(50)= 19 micromolxL(-1)) without changing the decay rate of macroscopic currents. In contrast, adiphenine did not change amplitude but increased the decay rate (IC(50)= 15 micromolxL(-1)). Kinetic measurements demonstrate that proadifen acts on the resting state to induce a desensitized state whose kinetics of recovery resemble those of ACh-induced desensitization. Adiphenine accelerates desensitization from the open state, but previous application of the drug to resting receptors is required. Both drugs stabilize desensitized states, as evidenced by the decrease in the number of clusters elicited by high ACh concentrations. The inhibition by adiphenine is not affected by proadifen, and the mutation alphaE262K decreases the sensitivity of the AChR only for adiphenine, indicating that these drugs act at different sites. CONCLUSIONS AND IMPLICATIONS: Two analogous local anaesthetics bind to different sites and inhibit AChR activity via different mechanisms and conformational states. These results provide new information on drug modulation of AChR.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19422391      PMCID: PMC2721265          DOI: 10.1111/j.1476-5381.2009.00214.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  37 in total

1.  Subunit-selective contribution to channel gating of the M4 domain of the nicotinic receptor.

Authors:  Cecilia Bouzat; Fernanda Gumilar; María del Carmen Esandi; Steven M Sine
Journal:  Biophys J       Date:  2002-04       Impact factor: 4.033

2.  The kinetics of competitive antagonism by cisatracurium of embryonic and adult nicotinic acetylcholine receptors.

Authors:  D Demazumder; J P Dilger
Journal:  Mol Pharmacol       Date:  2001-10       Impact factor: 4.436

3.  The kinetics of inhibition of nicotinic acetylcholine receptors by (+)-tubocurarine and pancuronium.

Authors:  I Wenningmann; J P Dilger
Journal:  Mol Pharmacol       Date:  2001-10       Impact factor: 4.436

4.  Desensitization of diliganded mouse muscle nicotinic acetylcholine receptor channels.

Authors:  Sergio Elenes; Anthony Auerbach
Journal:  J Physiol       Date:  2002-06-01       Impact factor: 5.182

Review 5.  Molecular and physicochemical aspects of local anesthetics acting on nicotinic acetylcholine receptor-containing membranes.

Authors:  Hugo R Arias; Michael P Blanton
Journal:  Mini Rev Med Chem       Date:  2002-08       Impact factor: 3.862

6.  Local anesthetics noncompetitively inhibit function of four distinct nicotinic acetylcholine receptor subtypes.

Authors:  C L Gentry; R J Lukas
Journal:  J Pharmacol Exp Ther       Date:  2001-12       Impact factor: 4.030

7.  A hydrophobic photolabel inhibits nicotinic acetylcholine receptors via open-channel block following a slow step.

Authors:  S A Forman
Journal:  Biochemistry       Date:  1999-11-02       Impact factor: 3.162

8.  The noncompetitive inhibitor quinacrine modifies the desensitization kinetics of muscle acetylcholine receptors.

Authors:  G Spitzmaul; J P Dilger; C Bouzat
Journal:  Mol Pharmacol       Date:  2001-08       Impact factor: 4.436

9.  A conformational intermediate between the resting and desensitized states of the nicotinic acetylcholine receptor.

Authors:  S E Ryan; M P Blanton; J E Baenziger
Journal:  J Biol Chem       Date:  2000-11-16       Impact factor: 5.157

10.  The insecticide fipronil and its metabolite fipronil sulphone inhibit the rat alpha1beta2gamma2L GABA(A) receptor.

Authors:  P Li; G Akk
Journal:  Br J Pharmacol       Date:  2008-07-28       Impact factor: 8.739

View more
  11 in total

1.  The nicotinic acetylcholine receptor and the Na,K-ATPase alpha2 isoform interact to regulate membrane electrogenesis in skeletal muscle.

Authors:  Judith A Heiny; Violetta V Kravtsova; Frederic Mandel; Tatiana L Radzyukevich; Boubacar Benziane; Alexander V Prokofiev; Steen E Pedersen; Alexander V Chibalin; Igor I Krivoi
Journal:  J Biol Chem       Date:  2010-07-01       Impact factor: 5.157

Review 2.  Structural basis of activation of cys-loop receptors: the extracellular-transmembrane interface as a coupling region.

Authors:  Mariana Bartos; Jeremías Corradi; Cecilia Bouzat
Journal:  Mol Neurobiol       Date:  2009-10-28       Impact factor: 5.590

Review 3.  Nicotinic acetylcholine receptors at the single-channel level.

Authors:  Cecilia Bouzat; Steven M Sine
Journal:  Br J Pharmacol       Date:  2017-04-08       Impact factor: 8.739

4.  Riluzole blocks human muscle acetylcholine receptors.

Authors:  Cristina Deflorio; Eleonora Palma; Luca Conti; Cristina Roseti; Alessia Manteca; Elena Giacomelli; Myriam Catalano; Cristina Limatola; Maurizio Inghilleri; Francesca Grassi
Journal:  J Physiol       Date:  2012-03-19       Impact factor: 5.182

5.  The pharmacological profile of ELIC, a prokaryotic GABA-gated receptor.

Authors:  Andrew J Thompson; Mona Alqazzaz; Chris Ulens; Sarah C R Lummis
Journal:  Neuropharmacology       Date:  2012-06-04       Impact factor: 5.250

6.  Phenylalanine in the pore of the Erwinia ligand-gated ion channel modulates picrotoxinin potency but not receptor function.

Authors:  Andrew J Thompson; Mona Alqazzaz; Kerry L Price; David A Weston; Sarah C R Lummis
Journal:  Biochemistry       Date:  2014-09-19       Impact factor: 3.162

7.  Bioinformatics analysis of the gene expression profile in Bladder carcinoma.

Authors:  Jing Xiao; Qiu Yiqing
Journal:  Genet Mol Biol       Date:  2013-04-12       Impact factor: 1.771

8.  Muscle-Type Nicotinic Receptor Modulation by 2,6-Dimethylaniline, a Molecule Resembling the Hydrophobic Moiety of Lidocaine.

Authors:  Armando Alberola-Die; Gregorio Fernández-Ballester; José M González-Ros; Isabel Ivorra; Andrés Morales
Journal:  Front Mol Neurosci       Date:  2016-11-24       Impact factor: 5.639

9.  Ruthenium-catalyzed umpolung carboxylation of hydrazones with CO2.

Authors:  Si-Shun Yan; Lei Zhu; Jian-Heng Ye; Zhen Zhang; He Huang; Huiying Zeng; Chao-Jun Li; Yu Lan; Da-Gang Yu
Journal:  Chem Sci       Date:  2018-04-30       Impact factor: 9.825

10.  Molecular mechanisms underlying variations in lung function: a systems genetics analysis.

Authors:  Ma'en Obeidat; Ke Hao; Yohan Bossé; David C Nickle; Yunlong Nie; Dirkje S Postma; Michel Laviolette; Andrew J Sandford; Denise D Daley; James C Hogg; W Mark Elliott; Nick Fishbane; Wim Timens; Pirro G Hysi; Jaakko Kaprio; James F Wilson; Jennie Hui; Rajesh Rawal; Holger Schulz; Beate Stubbe; Caroline Hayward; Ozren Polasek; Marjo-Riitta Järvelin; Jing Hua Zhao; Deborah Jarvis; Mika Kähönen; Nora Franceschini; Kari E North; Daan W Loth; Guy G Brusselle; Albert Vernon Smith; Vilmundur Gudnason; Traci M Bartz; Jemma B Wilk; George T O'Connor; Patricia A Cassano; Wenbo Tang; Louise V Wain; María Soler Artigas; Sina A Gharib; David P Strachan; Don D Sin; Martin D Tobin; Stephanie J London; Ian P Hall; Peter D Paré
Journal:  Lancet Respir Med       Date:  2015-09-21       Impact factor: 30.700

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.